Gel (repository corticotropin
injection) reduces certain measures of disease activity in patients with persistently active Systemic Lupus Erythematosus (SLE) who are receiving corticosteroid therapy.
Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin
releasing hormone and corticotropin
levels in alcoholics after recent and long-term abstinence.
releasing factor (CRF), a neuropeptide, is known to be related to these physiological functions and neurological disorders.
The Phase 2 trial, which involved 150 patients experiencing a major depressive episode, found no benefit for patients treated with the experimental drug, a corticotropin
releasing factor (CRF1) receptor antagonist called GSK561679.
Hydrocortisone is widely used in patients with septic shock even though a survival benefit has been reported only in patients whose blood pressure remained low after fluid and vasopressor resuscitation and whose cortisol levels did not rise appropriately after they received corticotropin
Cushing's syndrome attributable to ectopic secretion of corticotropin
in a patient with two neuroendocrine tumors.
Central regulation of gastric emptying of solid nutrient meals by corticotropin
Their topics include the life cycle of depression, considerations of cognitive, psychodynamic, and cognitive-behavioral theories, the role of development and its implications in childhood and adolescent depression, developments in psychodynamic development psychopathology such as complex developmental pathways, and the integration of psychology and neurobiology in such treatment tools as corticotropin
They studied the records of 119 patients who underwent scintigraphy of the adrenal cortex using iodine-131-aldosterol with dexamethasone suppression of the corticotropin
The Salk Institute for Biological Studies (La Jolla, CA) has patented a G-protein-coupled receptor proteins (CRF-R) characterized by having sufficient binding affinity for corticotropin
releasing factor (CRF) such that concentrations of 10 nM of CRF occupy 50% of the binding sites of said receptor protein.
3,5) These associated adrenal pathologic conditions include adrenocortical hyperplasia, (3) adrenocortical adenomas, (3,5) adrenocortical carcinomas, (5) and endocrinologic dysfunctions, including Addison disease, (4) Conn syndrome, (5) 21-hydroxylase deficiency, (3) 17-hydroxylase deficiency, (6) and ectopic corticotropin